Page 24 - Recommendation Statement News Today

OpenText™  announced today that it has commenced its previously announced tender offer for all outstanding shares of common stock of Zix Corporation at a price of U.S. $8.50 per share, through its subsidiary, Zeta Merger Sub Inc.  The tender offer is being made in connection with the Agreement and Plan of Merger, dated as of November 7, 2021 by and among OpenText, Zeta Merger Sub Inc. and Zix, which OpenText and ...

/PRNewswire/ -- Dawson Geophysical Company (NASDAQ: DWSN) (the "Company") today reports its unaudited financial results for its third quarter ended September...

/PRNewswire/ -- Southwest Gas Holdings, Inc. (NYSE: SWX) today confirmed that Icahn Enterprises LP ("Icahn") has commenced an unsolicited tender offer to...

/PRNewswire/ -- Dawson Geophysical Company (NASDAQ: DWSN) ("Dawson" or the "Company") and Wilks Brothers, LLC ("Wilks") today announced that they have entered...

Merck known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. . On Sept. 30, 2021, Merck announced that it had entered into a definitive agreement to acquire Acceleron. Upon the successful closing of the tender offer, stockholders of Acceleron will receive $180 in cash for each share ...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Acceleron Pharma Inc. (Nasdaq: XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Acceleron for $180 per share ...

Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development — Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas — — Fast tracks establishment of Sanofi’s recently announced  mRNA Center of Excellence — — Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology — PARIS and LEXINGTON, Mass., Aug. 03, 2021...

/PRNewswire/ -- Thoma Bravo and Talend (NASDAQ: TLND) ("Talend or "the Company") today announced that Thoma Bravo has commenced the previously-announced tender...

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Iconix Brand Group, Inc. (NASDAQ:ICON) ("Iconix" or the "Company") today announced it has entered into a ...

Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 Bolsters Position in Hematology-Oncology and Expands into Solid Tumors Best-in-Class